Article
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
The Cochrane database of systematic reviews - 17 Dec 2020
Southern Kevin W, Murphy Jared, Sinha Ian P, Nevitt Sarah J
Abstract excerpt
BACKGROUND: Cystic fibrosis (CF) is a common life-shortening genetic condition caused by a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. A class II CFTR variant F508del (found in up to 90% of people with CF (pwCF)) is the commonest CF-causing variant. The faulty protein is degraded before reaching the cell membrane, where it needs to be to effect transepithelial salt...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.